Researchers Zhi Sheng and Rob Gourdie at Virginia Tech’s Fralin Biomedical Research Institute at VTC have developed an encouraging three-pronged approach to treating glioblastoma, an aggressive brain cancer with an average survival time of approximately 15 months. Their findings published this week in Oncogenesis.

Learn more here.

< Back